Bank of New York Mellon’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $906K | Sell |
56,671
-4,049
| -7% | -$64.7K | ﹤0.01% | 3164 |
|
|
2025
Q1 | $924K | Sell |
60,720
-539
| -0.9% | -$8.2K | ﹤0.01% | 3101 |
|
|
2024
Q4 | $1.24M | Sell |
61,259
-179
| -0.3% | -$3.63K | ﹤0.01% | 3008 |
|
|
2024
Q3 | $1.58M | Sell |
61,438
-9,259
| -13% | -$238K | ﹤0.01% | 2866 |
|
|
2024
Q2 | $909K | Buy |
+70,697
| New | +$909K | ﹤0.01% | 3256 |
|
|
2023
Q4 | – | Sell |
-2,069
| Closed | -$58.1K | – | 4374 |
|
|
2023
Q3 | $58.1K | Hold |
2,069
| – | – | ﹤0.01% | 4142 |
|
|
2023
Q2 | $62.9K | Sell |
2,069
-3,787
| -65% | -$115K | ﹤0.01% | 4129 |
|
|
2023
Q1 | $110K | Hold |
5,856
| – | – | ﹤0.01% | 4054 |
|
|
2022
Q4 | $59.7K | Sell |
5,856
-725
| -11% | -$7.4K | ﹤0.01% | 4208 |
|
|
2022
Q3 | $173K | Buy |
6,581
+712
| +12% | +$18.7K | ﹤0.01% | 4064 |
|
|
2022
Q2 | $265K | Sell |
5,869
-93
| -2% | -$4.2K | ﹤0.01% | 3942 |
|
|
2022
Q1 | $586K | Buy |
5,962
+620
| +12% | +$60.9K | ﹤0.01% | 3620 |
|
|
2021
Q4 | $817K | Buy |
5,342
+2,600
| +95% | +$398K | ﹤0.01% | 3499 |
|
|
2021
Q3 | $372K | Buy |
2,742
+1,064
| +63% | +$144K | ﹤0.01% | 3953 |
|
|
2021
Q2 | $246K | Buy |
+1,678
| New | +$246K | ﹤0.01% | 4028 |
|